3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
17
Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
3
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Respiratory Tract Diseases
1
Papillary renal cell carcinoma, sporadic
1
Pancreatic Intraductal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms, Squamous Cell
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Hereditary leiomyomatosis and renal cell cancer
1
Interventions
ruxolitinib
24
Cyclophosphamide
13
Whole-Body Irradiation
10
Tacrolimus
9
Mycophenolic Acid
9
fludarabine phosphate
8
fludarabine
8
Stem Cell Transplantation
8
Specimen Handling
7
Peripheral Blood Stem Cell Transplantation
7
Azacitidine
6
Busulfan
5
navitoclax
4
Sirolimus
4
Melphalan
4
Biopsy
4
luspatercept
3
fedratinib
3
Methotrexate
3
Injections
3
Cyclosporine
3
venetoclax
2
selinexor
2
parsaclisib
2
letermovir
2
itacitinib
2
bomedemstat
2
INCB057643
2
INCB039110
2
Hematopoietic Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Erlotinib Hydrochloride
×
1 year
×
Clear all
No trials found.